Biossance copper peptide serum vs the ordinary, compared

Last updated 2026-07-24

what are biossance copper peptide serum and the ordinary's copper peptide product, actually

Biossance sells a product called Copper Peptide Rapid Renewal Serum, positioned as a resurfacing, texture-focused serum with copper peptides alongside other actives. The Ordinary's relevant product is usually "Buffet" + Copper Peptides 1%, which is its multi-peptide serum with a copper peptide complex blended in, not a standalone copper peptide product at a stated GHK-Cu percentage. That distinction matters more than most reviews let on. Neither brand publishes the exact GHK-Cu concentration on the label, and neither has run or published a clinical trial on the finished serum itself. What you're buying, in both cases, is a cosmetic formulation where copper peptide is one ingredient in a longer list, not a dosed, standardized active the way you'd see in a drug product. Compare that to the peptide research base. The core GHK-Cu science comes from decades of work summarized in reviews like "Regenerative and Protective Actions of the GHK-Cu Peptide in the Light of the New Gene Data" ^[1] and "The potential of GHK as an anti-aging peptide" ^[2], both of which describe cell signaling and gene expression effects from purified GHK-Cu in lab and animal systems. That's a different object than a bottled serum sitting on a bathroom shelf.

is biossance copper peptide serum better than the ordinary's copper peptide serum

Nobody has published a study comparing these two specific products, so any "better" claim is marketing, not evidence. What can be compared honestly is price, formulation philosophy, and what each brand asks you to take on faith. Biossance costs more per bottle and layers copper peptides with other resurfacing ingredients (its Rapid Renewal line has leaned on acids and retinol alternatives in other SKUs), which makes it harder to isolate what the copper peptide is contributing versus everything else in the bottle. The Ordinary's Buffet + Copper Peptides 1% is cheaper and marketed more plainly as a multi-peptide anti-aging serum with copper peptides added to its existing Buffet formula, again a blend, not a solo act. | Factor | Biossance Copper Peptide Serum | The Ordinary Buffet + Copper Peptides 1% |

what does the actual research say about topical ghk-cu for skin

The topical evidence is real but narrower than the marketing suggests. A 2025 review in BioImpacts, "Topically applied GHK as an anti-wrinkle peptide: Advantages, problems and prospective," lays out both the mechanistic case for GHK-Cu's anti-wrinkle effects and the practical problems with delivering it through skin ^[3]. That paper's framing, advantages and problems in the same title, is a fair summary of where the field actually stands. A fibroblast and ex-vivo skin study found that combining GHK-Cu with hyaluronic acid upregulated collagen IV in a way stronger than either ingredient alone ^[4], which is a specific, real result in skin tissue models, not a claim about a finished consumer serum. Separately, a 2017 study found GHK-Cu delivered via liposomes accelerated scald wound healing in mice by promoting cell proliferation and angiogenesis ^[5], again a wound-healing model, not a cosmetic anti-aging trial on human faces. The thread connecting all of this: GHK-Cu has real, repeatable biological activity in cells and animal wound models. Whether that activity survives being formulated at an undisclosed percentage in a leave-on face serum, applied once or twice daily by a person with intact, non-wounded skin, is the part nobody has directly tested.

why is skin penetration such a problem for copper peptide serums

GHK-Cu is a small tripeptide with a bound copper ion, and getting it through the stratum corneum in a stable, active form is a genuine formulation challenge, not a solved problem. A 2025 study in Molecules asked directly, "Are We Ready to Measure Skin Permeation of Modern Antiaging GHK-Cu Tripeptide Encapsulated in Liposomes?" and the fact that this question is still being asked in 2025 tells you the measurement science itself is unsettled ^[6]. Liposome encapsulation is the leading approach researchers use to try to improve delivery. A 2023 Pharmaceutics paper, "Liposomes as Carriers of GHK-Cu Tripeptide for Cosmetic Application," tested this directly ^[7], and a related 2024 Electrophoresis paper used CE-ICP-MS/MS to monitor how much GHK-Cu actually ends up encapsulated in liposome cosmetic preparations ^[8]. Neither Biossance nor The Ordinary discloses whether their copper peptide is liposome-encapsulated, at what concentration, or how it was tested for stability and penetration. That's not unusual for cosmetic-grade skincare (labeling law doesn't require it), but it does mean you're trusting the brand's formulation chemistry sight unseen, not verifying anything the published penetration research has actually measured.

topical vs injectable ghk-cu: why the evidence doesn't transfer

This is the single most important distinction in the copper peptide space, and it gets blurred constantly in product marketing. Injectable and provider-dispensed GHK-Cu is a different exposure route with different research, different oversight, and different risk profile than a cosmetic serum rubbed onto intact skin. The injectable and orthopedic literature is a separate body of work. "Injectable Peptide Therapy: A Primer for Orthopaedic and Sports Medicine Physicians," published in 2026, frames GHK-Cu and related peptides for physicians considering injectable use in musculoskeletal contexts ^[9]. A companion 2026 paper, "Safety and Efficacy of Approved and Unapproved Peptide Therapies for Musculoskeletal Injuries and Athletic Performance," reviews the safety data specifically for these unapproved uses ^[10]. Neither of these papers is about facial serums, and neither validates a cosmetic product's claims. An earlier rat study on ACL reconstruction found that GHK-Cu(II) "transiently improved healing outcome" ^[11], with the word transiently doing real work there: the benefit did not appear to be durable. That's a materially different claim than "reduces wrinkles," and it comes from injected peptide in a joint reconstruction model, not skin. If you're researching the injectable route specifically, read ghk-cu peptides injections and ghk cu dosage before assuming anything you read about a $30 serum applies. It doesn't.

is copper peptide safe to use every day on your face

For most people, a cosmetic copper peptide serum used as directed is unlikely to cause acute problems, but "safe" needs qualifying, because copper is not a benign substance at every dose or route. Topical absorption through intact skin is low compared to injection or oral intake, and that's the main reason cosmetic use has a different risk profile than provider-dispensed use. That said, copper accumulation is a real physiological concern in general, particularly for anyone with a copper metabolism disorder (like Wilson's disease) or anyone stacking multiple copper-containing products and supplements without tracking total exposure. The research pack here doesn't include a topical human safety trial quantifying systemic copper uptake from a face serum, and that absence is itself worth naming rather than glossing over. For a fuller rundown of documented and theoretical adverse effects across topical and injectable use, see ghk-cu side effects. If you're using a cosmetic serum alongside a provider-dispensed compounded product, that stacking question is exactly the kind of thing a prescriber reviewing your case should know about.

does copper peptide serum actually help with wrinkles and firmness

There's a plausible mechanism, and it's better characterized than most cosmetic ingredient stories. GHK-Cu's role in stimulating collagen and related extracellular matrix activity is documented across multiple lab studies, including the collagen IV work with hyaluronic acid ^[4] and the broader review of its gene-level regenerative actions ^[1]. What's missing is the last link in the chain: a published, controlled clinical trial measuring wrinkle depth, firmness, or elasticity in human subjects using a specific finished cosmetic serum at a disclosed concentration, over a defined time period, against a placebo. That trial doesn't appear in the current literature for either Biossance's or The Ordinary's product. The anti-aging review from 2020 discusses GHK-Cu's potential as an anti-aging peptide broadly ^[2], and the 2025 BioImpacts review explicitly frames the anti-wrinkle case as having both advantages and unresolved problems ^[3], which is the most balanced verdict available right now. So: plausible mechanism, real cell and tissue biology, no finished-product human trial. That's a fair place to land, and it's a more honest answer than either brand's marketing copy gives you.

how much ghk-cu is actually in these serums

Neither brand states it, and that's normal for the cosmetic category, not a red flag specific to these two products. Cosmetic ingredient labeling in the US requires listing ingredients in descending order of concentration above 1%, then in any order below 1% (per FDA cosmetic labeling rules), but it does not require disclosing an exact percentage for a peptide complex, especially one sold as part of a proprietary blend. The research studies cited throughout this article generally use purified GHK-Cu at specified concentrations in cell culture or animal models, not the diluted, blended form found in a retail serum. A study might use GHK-Cu at a defined micromolar concentration directly on fibroblasts ^[4] or in a mouse wound model ^[5], concentrations and exposure conditions that have no fixed relationship to whatever ends up in a 30 mL bottle of face serum. This is the single biggest gap between the marketing claim ("contains copper peptides, backed by science") and the actual evidence (studies used a different concentration, in a different system, applied a different way). If concentration transparency matters to you, a provider-reviewed compounded option, discussed below, is the more auditable path.

what about copper peptides for hair thinning, is that the same evidence

Copper peptide's reputation for hair sits mostly on GHK-Cu's general tissue remodeling and follicle biology story rather than a dedicated human hair growth trial in the citation set here. The foundational paper "The human tri-peptide GHK and tissue remodeling," from 2008, describes GHK's broad role in stimulating tissue repair processes, which is the mechanistic basis people extrapolate from to justify scalp use ^[12]. That extrapolation is reasonable as a hypothesis. It is not the same as a published trial measuring hair density or count from a topical copper peptide scalp serum. If you're specifically researching hair claims, treat scalp serums the same way this article treats face serums: real underlying peptide biology, no finished-product trial confirming the marketing claim at the concentration actually sold.

should i buy an over-the-counter serum or go the provider-reviewed route

That depends on what you're actually trying to solve. For general skin texture and a low-commitment way to test whether you tolerate copper peptides, an over-the-counter serum like Biossance's or The Ordinary's is a reasonable, low-cost entry point, and neither is likely to be dangerous used as directed. For anything where you want confidence about actual GHK-Cu content, purity testing, and a documented product rather than a proprietary blend, a provider-reviewed compounded route is the more transparent option. Compounded copper peptide preparations dispensed under a prescriber's review fall under different rules than cosmetic serums: bulk drug substances used in 503A pharmacy compounding are governed by 21 CFR 216.23 ^[13] and 21 U.S.C. 353a ^[14], while outsourcing facilities compounding in larger batches fall under the 503B bulks list at 21 CFR 216.24 ^[15]. That's a real regulatory framework with documentation requirements that a $38 bottle of face serum simply doesn't have to meet. Copper Peptide Direct's own positioning here is straightforward: cosmetic serums and provider-dispensed compounded preparations are different products with different oversight, and conflating them does readers a disservice. If you want to compare what a provider-reviewed compounded copper peptide product actually looks like against a retail serum, buy ghkcu covers sourcing considerations directly.

what should i actually do with this information

If you want a cheap, low-stakes way to try copper peptides on your skin, The Ordinary's product costs less and is a reasonable starting point; Biossance costs more and bundles in additional resurfacing actives that may matter more to your results than the copper peptide line item does. Neither has been tested against the other, and neither has a published trial on the finished bottle, so don't pay premium prices expecting clinical-grade evidence to back the specific product. If your interest is genuinely about wound healing, post-procedure skin recovery, or something closer to what the deeper GHK-Cu literature actually studies (cell proliferation, angiogenesis, collagen signaling), read the primary evidence roundup at ghk-cu and the before-and-after evidence summary at ghk-cu peptide injection before and after before assuming a retail serum gets you there. And if you're weighing a provider-reviewed compounded route against these serums, get the dosage and safety context first: ghk cu dosage and ghk-cu side effects both cover ground that neither Biossance nor The Ordinary's marketing addresses.

Frequently asked questions

Is Biossance Copper Peptide Serum better than The Ordinary's copper peptide serum?

There's no published head-to-head trial, so no one can say definitively. Biossance costs more and blends copper peptides with additional resurfacing actives; The Ordinary is cheaper and blends it into its existing Buffet peptide complex. Neither discloses GHK-Cu concentration, so the comparison mostly comes down to price, texture preference, and the rest of each formula.

What percentage of GHK-Cu is in these serums?

Neither brand publishes an exact percentage. US cosmetic labeling rules require ingredients to be listed in descending order of concentration but don't require disclosing an exact percentage for a peptide complex, so you can't compare dose between products from the label alone.

Does copper peptide serum actually reduce wrinkles?

There's a plausible mechanism from cell and tissue studies on collagen signaling and gene expression, including a 2025 BioImpacts review of GHK-Cu as an anti-wrinkle peptide, but no published clinical trial testing a specific finished retail serum for wrinkle reduction in humans currently exists in the literature.

Is topical copper peptide the same as injectable GHK-Cu?

No. Topical serums rely on skin penetration, which is a documented formulation challenge, while injectable GHK-Cu is dispensed under provider review with a separate research base covering musculoskeletal and wound applications. Evidence from one route does not transfer to the other.

Can copper peptide serum cause copper toxicity?

Topical absorption through intact skin is generally low, making acute toxicity from a cosmetic serum unlikely with normal use. Copper accumulation is still a real concern in general, especially for people with copper metabolism disorders or those stacking multiple copper-containing products without tracking total exposure.

Why is copper peptide hard to formulate into a stable serum?

GHK-Cu is a small copper-bound tripeptide, and keeping it stable and able to penetrate skin is a genuine chemistry problem. Researchers have turned to liposome encapsulation to try to improve delivery, and a 2025 Molecules paper questioned whether measurement science for skin permeation of encapsulated GHK-Cu is even adequate yet.

Do copper peptide serums help with hair thinning?

The case rests mostly on GHK-Cu's general tissue remodeling biology described in foundational research from 2008, not a dedicated clinical trial on a scalp serum measuring hair density or count. Treat hair claims with the same caution as skin claims: real underlying biology, no finished-product trial.

What's the difference between cosmetic-grade and provider-dispensed copper peptide?

Cosmetic serums are regulated as cosmetics with looser disclosure requirements and no prescriber review. Provider-dispensed compounded copper peptide falls under pharmacy compounding rules (21 U.S.C. 353a and the 503A/503B bulk substance lists), which involve documentation and oversight a retail serum bottle doesn't require.

Has anyone studied GHK-Cu for actual wound healing, more than cosmetics?

Yes, this is where the GHK-Cu literature is deepest. A 2017 study found liposome-delivered GHK-Cu accelerated scald wound healing in mice through increased cell proliferation and angiogenesis, and separate work has tested it in hydrogel wound dressings for infected wounds.

Should I use a copper peptide serum with retinol or acids?

The research pack reviewed here doesn't include a specific interaction trial for GHK-Cu combined with retinoids or acids in a finished serum. Biossance's product already layers copper peptides with resurfacing actives; if you're combining separate products, introduce one at a time and watch for irritation.

Is The Ordinary's copper peptide serum a standalone product?

No. The Ordinary sells copper peptides folded into its Buffet multi-peptide serum, not as an isolated single-ingredient product with a stated GHK-Cu percentage. That makes it hard to credit or blame copper peptide specifically for any result you see.

Where does the real GHK-Cu research come from if not these serum brands?

It comes from independent peer-reviewed lab, animal, and (for injectable/orthopedic use) clinical research, published in journals like the International Journal of Molecular Sciences, Wound Repair and Regeneration, and the American Journal of Sports Medicine, not from cosmetic company trials on their own finished products.

Sources

1. International Journal of Molecular Sciences, 2018 (PMID 29986520): Reviews GHK-Cu's regenerative and protective gene-level actions based on newer gene expression data.
2. Aging Pathobiology and Therapeutics, 2020 (PMID 35083444): Discusses the potential of GHK as an anti-aging peptide.
3. BioImpacts, 2025 (PMID 39963574): Reviews topical GHK's anti-wrinkle potential alongside its formulation and delivery problems.
4. Journal of Cosmetic Dermatology, 2023 (PMID 37062921): Found GHK-Cu combined with hyaluronic acid upregulated collagen IV more than either ingredient alone in fibroblast and ex-vivo skin tests.
5. Wound Repair and Regeneration, 2017 (PMID 28370978): GHK-Cu liposomes accelerated scald wound healing in mice via increased cell proliferation and angiogenesis.
6. Molecules, 2025 (PMID 39795193): Questions whether current methods are adequate to measure skin permeation of liposome-encapsulated GHK-Cu.
7. Pharmaceutics, 2023 (PMID 37896245): Tests liposomes as carriers for GHK-Cu tripeptide in cosmetic application.
8. Electrophoresis, 2024 (PMID 39451062): Uses CE-ICP-MS/MS to monitor GHK-Cu encapsulation levels in liposome cosmetic preparations.
9. American Journal of Sports Medicine, 2026 (PMID 41476424): Provides a primer on injectable peptide therapy, including GHK-Cu, for orthopedic and sports medicine physicians.
10. Sports Medicine (Auckland, N.Z.), 2026 (PMID 41966639): Reviews safety and efficacy data for approved and unapproved peptide therapies used for musculoskeletal injuries.
11. Journal of Orthopaedic Research, 2015 (PMID 25731775): Found GHK-Cu(II) transiently improved healing outcome in a rat model of ACL reconstruction.
12. Journal of Biomaterials Science, Polymer Edition, 2008 (PMID 18644225): Foundational description of the human tri-peptide GHK's role in tissue remodeling.
13. eCFR, 21 CFR 216.23: Establishes the final bulks list for substances usable in 503A pharmacy compounding.
14. Cornell Law/Legal Information Institute, 21 U.S.C. 353a: Sets the statutory framework for pharmacy compounding under section 503A.
15. eCFR, 21 CFR 216.24: Establishes the bulks list for substances usable by 503B outsourcing facilities.